Discordant perspectives of rheumatologists and patients on COBRA combination therapy in rheumatoid arthritis

Rheumatology

Volumn 47, Issue 10, 2008, Pages 1571-1576

  Van Tuyl, L H D ^a   Plass, A M C ^a   Lems, W F ^a   Voskuyl, A E ^a   Kerstens, P J S M ^b   Dijkmans, B A C ^a   Boers, M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b JAN VAN BREEMEN INSTITUTE   (Netherlands)

Author keywords

COBRA therapy; Combination therapy; Focus group; Glucocorticoids; Patient perspective; Qualitative; Rheumatoid arthritis

Indexed keywords

GLUCOCORTICOID; METHOTREXATE; PREDNISOLONE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ANTIBODY;

ADD ON THERAPY; ARTICLE; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; DRUG DOSE REDUCTION; DRUG MEGADOSE; FACE DISORDER; FEMALE; HUMAN; INTERVIEW; MALE; MEDICAL SPECIALIST; NETHERLANDS; PATIENT ATTITUDE; PHYSICIAN ATTITUDE; PILL; PRESCRIPTION; PRIORITY JOURNAL; PROGNOSIS; QUALITATIVE RESEARCH; RHEUMATOID ARTHRITIS; SIDE EFFECT; WEIGHT GAIN;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; ATTITUDE OF HEALTH PERSONNEL; ATTITUDE TO HEALTH; DRUG THERAPY, COMBINATION; FEMALE; FOCUS GROUPS; HUMANS; MALE; METHOTREXATE; NETHERLANDS; PHYSICIAN'S PRACTICE PATTERNS; PREDNISOLONE; SULFASALAZINE;

EID: 52949106516     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken323     Document Type: Article

References (24)

1. Breedveld FC, Weisman MH, Kavanaugh AF et al. The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum 2006;54:26-37.
2. Mottonen T, Hannonen P, Leirisalo-Repo M et al. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: A randomised trial. FIN-RACo trial group. Lancet 1999;353:1568-73.
3. O'Deil JR, Haire CE, Erikson N et al. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications. N Engl J Med 1996;334:1287-91,
4. Smolen JS, Han C, Bala M et al. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: A detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study. Arthritis Rheum 2005;52:1020-30.
5. van der Heijde DM, Klareskog L, Rodriguez-Valverde V et al. Comparison of etanercept and methotroxate, alone and combined, in the treatment of rheumatoid arthritis: Two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial. Arthritis Rheum 2006;54:1063-74.
6. Combe B, Landewé RB, Lukas C et al. EULAR recommendations for the management of early arthritis: Report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2007;66:34-45.
7. Boers M, Verhoeven AC, Markusse HM et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 1997;350:309-18.
8. Korthals-de Bos IBC, van Tulder MW, Boom M et al. Indirect and total cost of early rheumatoid arthritis: A randomised comparison of combined step-down prednisolons, methotrexate, and sulphasalazine alone. J Rheumatol 2004; 31:1709-16.
9. Verhoeven AC, Bibo JC, Boers M, Engel GL, van der Linden S. Cost-effectiveness and cost-utillty of combination therapy in early rheumatoid arthritis: Randomized comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone. Br J Rheumatol 1998;37:1102-9.
10. Landewé RB, Boers M, Verhoeven AC et al. COBRA combination therapy in patients with early rheumatoid arthritis: Long-term structural benefits of a brief intervention. Arthritis Rheum 2002;46:347-56.
11. Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled tried. Arthritis Rheum 2005;52:3381-90.
12. Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF et al. Comparison of treatment strategies in early rheumatoid arthritis: A randomized trial. Ann Intern Med 2007;146:406-15.
13. van Tuyl LH, Plass AM, Lems WF, Voskuyl AE, Dijkmans BA, Boers M. Why are Dutch rheumatologists reluctant to use the COBRA treatment strategy in early rheumatoid arthritis? Ann Rheum Dis 2007;66:974-6.
14. Krueger RA, Casey MA. Focus groups: A practical guide for applied research. California: Sage Publications, 2000.
15. Smith J. Beyond the divide between cognition and discourse: Using interpretative phenomenological analysis in health psychology. Psychol Health 1996; 11:261-71
16. Smith JA, Osborn M. Interpretative phenomenological analysis. In: Smith JA, ad, Qualitative psychology: A practical guide to research methods. London: Sage, 2003;51-80.
17. Haagsma CJ, van Riel PL, de Jong AJ, van de Putte LB. Combinatipn of sulphasalazine and methotrexate versus the single components in eady rheumatoid arthritis: A randomized, controlled, double-blind, 52 week clinical trial. Br J Rheumatol 1997;36:1082-8.
18. Ahlmen M, Nordenskiold U, Archenholtz B et al. Rheumatology outcomes: The patient's perspective. A multicentre focus group interview study of Swedish rheumatoid arthritis patients. Rheumatology 2005;44:105-10.
19. Varekamp I, Haafkens JA, Detaille SI, Tak PP, van Dijk FJ. Preventing work disability among employees with rheumatoid arthritis: What medical professionals can learn from the patients' perspective. Arthritis Rheum 2005;53:965-72.
20. Leeb BF, Sautner J, Leeb BA, Fassi C, Rintelen B. Lack of agreement between patients' and physicians' perspectives of rheumatoid arthritis disease activity changes. Scand J Rheumatol 2006;35:441-6.
21. Spoorenberg A, van TA, Landewe R et al. Measuring dissease activity in ankylosing spondylitis: Patient and physician have different perspectives. Rheumatology 2005;44:789-95.
22. Kirwan JR, Hewlett SE, Heiberg T et al. Incorporating the patient perspective into outcome assessment in rheumatoid arthritis - progress at OMERACT 7. J Rheumatol 2005;32:2250-6.
23. Kirwan JR, Minnock P, Adebajo A et al. Patient perspective: fatigue as a recommended patient centered outcome measure in rheumatoid arthritis. J Rheumatol 2007;34:1174-7.
24. Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF et al. Patient preferences treatment: Report from a randomised comparison of treatment strategies in early rheumatoid arthritis (BeSt trial). Ann Rheum Dis 2007;66:1227-32.